Krka Enjoys 9% Pharma Sales Growth At The Half-Way Stage
Growth In All Six Geographic Segments Aids Krka; EBITDA Margin Above Guidance
Krka insisted that its margins were “stable and high,” as the Slovenian firm reported another solid quarter.
Krka insisted that its margins were “stable and high,” as the Slovenian firm reported another solid quarter.